Overview
This study aims to explore Survival Outcome of EGFR-TKI in Uncommon EGFR Mutant Advanced Non-small Cell Lung Cancer in China
Description
inclusion criteria Uncommon EGFR Mutant Advanced Non-small Cell Lung Cancer EGFR G719X, exon 20 insert mutation without any anti-cancer treatment history
Eligibility
Inclusion Criteria:
- 18,Advanced Non-squamous Non-small Cell Lung Cancer Confirmed by Histopathology
- Uncommon EGFR Mutant Advanced NSCLC
Exclusion Criteria:
- Patients with contraindication of chemotherapy
- Pregnant or breast feeding women